Skip to main content

Table 1 Patients treated for primary breast cancer

From: Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)

n

12

Age (median and range)

53 (39-67)

Staging

 

   IIA

2

   IIB

4

   IIIA

2

   IIIB

4

Receptor

 

   ER/PR +/+

4

   ER/PR +/-

6

   ER/PR-/-

2

HER2/neu +

6

  1. Staging was done according to the American Joint Committee on Cancer TNM system. ER: Estrogen receptor; PR: progesterone receptor
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us